Biofrontiers scientist, Hubert Yin, is using fluorescent biomarkers to develop a better screening method for cancer.

Biomarkers light the way to cancer diagnosis

Sept. 13, 2011

Biomarkers light the way to cancer diagnosis In an 18-year study released this summer by the National Cancer Institute, widespread screening for ovarian cancer was found to be ineffective in catching the disease. In fact, the screening often did more harm than good, leading women to unnecessary surgery and the...

The Jennie Smoly Caruthers Biotechnology Building may receive high marks from the U.S. Green Building Council.

Biotech building update: LEED certification

Sept. 8, 2011

A drive westbound on Colorado Avenue puts the new Jennie Smoly Caruthers Biotechnology Building front and center on CU-Boulder’s East Campus. When complete, the building may be the “greenest” academic research lab in the country. The building, nearing completion, is still tracking steadily for a high LEED Gold rating. In...

Kristi Anseth

Kristi Anseth Lecture: "The Body Shop"

Aug. 23, 2011

CIMB’s Dr. Kristi Anseth, distinguished professor of Chemical and Biological Engineering and Howard Hughes Medical Institute Investigator, will present “The Body Shop,” a lecture on her work in engineering tissues to improve medical treatments, from helping broken bones heal faster to replacing diseased heart valves. The lecture is scheduled for...


Heart disease: Snakes may hold the answers

Aug. 5, 2011

The Python Project, led by CIMB's Chief Scientific Officer Leslie Leinwand, is exploring uncharted territory in heart disease. And snakes are leading the charge. Pythons can eat large meals, often 50 to 75 percent of their total body weight. When they do, their hearts and other organs enlarge to process...


CIMB scientist's experiment on last space shuttle flight

July 8, 2011

CIMB faculty member, Virginia Ferguson, is stowing away a few special subjects on the last flight of the space shuttle program. Space Shuttle Atlantis is slated to launch on July 8 with Ferguson's "astromice," who may lead her toward a new treatment for bone loss. The study, a collaboration between...

hubert yin

Thinking out of the box for a cancer cure

June 16, 2011

CIMB scientist, Hubert Yin, describes how he is stepping out of his comfort zone in search of a better understanding of cancer. Read more in this interview.


Supporters celebrate building cornerstone

May 20, 2011

Supporters celebrate building cornerstone Donors for the Jennie Smoly Caruthers Biotechnology Building and for the CIMB program, gathered on May 9 to celebrate the placement of the building’s cornerstone. To commemorate the event, a time capsule was buried near the building containing a variety of mementoes to be rediscovered 100...

IQ Bio

IQ Biology Ph.D. program will prepare a new generation of bioscience leaders

Dec. 6, 2010

The Interdisciplinary Quantitative Biology program (IQ Biology) will enroll its first students in the fall semester of 2011. This unique program crosses eight academic departments to provide broad training in science, mathematics, engineering and technology. It will also expose students to the collaborative, interdisciplinary scientific culture necessary for future success...

CIMB's Tom Cech and Leslie Leinwand present the Charlie Butcher Award to Paul Nurse prior to his seminar at CU-Boulder.

Sir Paul Nurse Receives the 2010 Charlie Butcher Award

Nov. 11, 2010

Nobel Laureate and President of Rockefeller University in New York, Paul Nurse, Ph.D. recently received the 2010 Charlie Butcher Award in Biotechnology for his work in the molecular mechanisms that control cell division and cell shape. This work has furthered our understanding of cell reproduction, growth and development, particularly in...

Robin Dowell, Ph.D., recently received the Boettcher Award for early-career biomedical investigators.

Boettcher Investigator Envisions Personalized Medicine

Sept. 17, 2010

Dowell is an assistant professor of molecular, cellular and developmental biology, and will use her grant to advance research into why closely related people respond differently to drug treatments. Her work has the potential to assess more accurately the efficacy of specific treatments for individual patients. “The rapid drop in...